Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Theseus Pharmaceuticals Inc (NQ: THRX )

9.530 +0.450 (+4.96%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 6, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 123,807
Open 9.070
Bid (Size) 9.260 (2)
Ask (Size) 10.00 (3)
Prev. Close 9.080
Today's Range 9.010 - 9.710
52wk Range 4.010 - 14.77
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga

Performance

YTD
+82.92%
+82.92%
1 Month
-16.99%
-16.99%
3 Month
+7.93%
+7.93%
6 Month
+72.96%
+72.96%
1 Year
+61.53%
+61.53%

More News

Read More
Recap: Theseus Pharmaceuticals Q1 Earnings
Via Benzinga
Stifel Is Bullish On This 'Competitive Late-Comer' In Gastric Cancer Space
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2023
Via Benzinga
HC Wainwright Sees Over 300% Upside In This Cancer-Focused Stock
Via Benzinga
Why Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Analyst Bullish On Theseus Pharma's Platform For Gastric Cancer Therapies
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
Via Benzinga
Why Tattooed Chef Shares Dipped Around 15%; Here Are 95 Biggest Movers From Friday
Via Benzinga
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday
Via Benzinga
Around $5 Million Bet On This Financial Services Stock? Check Out 4 Stocks Insiders Are Buying
Via Benzinga
Recap: Theseus Pharmaceuticals Q3 Earnings
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2022
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Bristol Myers Snaps Up Turning Point For $4.1 Billion In Cash — Is The Biotech Bear Dead?
Via Investor's Business Daily
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
71 Biggest Movers From Yesterday
Via Benzinga
58 Biggest Movers From Friday
Via Benzinga
52 Biggest Movers From Friday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.